Clinical Effects of Isosorbide 5-Mononitrate(Elantan(R)) on Angina Pectoris
Korean Circulation Journal
;
: 815-818, 1990.
Artículo
en Coreano
| WPRIM
| ID: wpr-92872
ABSTRACT
An open trial was carried out to investigate the efficacy and tolerance of isosorbide 5-mononitrate(Elantan(R)) in 30 patients diagnosed as angina pectoris at Pusan national university hospital. Drugs were given 20mg two times daily for 2 to 3 weeks and the results were assessed in terms of effects on anginal pain and untoward side effects experienced during administration of medication. Treament resulted in an overall improvement in 25 patients(83.4%), complete abolition of anginal attacks in 17 patients(56.7%) and reduction in frequency of attacks in 8 patients(26.7%). So called "Nitrated headache" was observed in 5 patients(16.6%) but improved with proceeding of administration in 3 patients. This trial indicates that isosorbide 5-mononitrate should be efficacious as well as tolerated in patients with coronary heart disease.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Enfermedad Coronaria
/
Isosorbida
/
Angina de Pecho
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Circulation Journal
Año:
1990
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS